Systemic adverse drug reactions: A preliminary report from the regional pharmacovigilance center, Western Nepal

Pakistan Journal of Pharmaceutical Sciences

Volumn 21, Issue 4, 2008, Pages 465-467

  Subish, P ^a,b   Mishra, P ^a   Shankar, P R ^b  

^a MANIPAL TEACHING HOSPITAL   (Nepal)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Adverse drug reactions; Nepal; Pharmacovigilance; Systemic toxicity.

Indexed keywords

NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL TRACT; HOSPITALIZATION; HUMAN; INFANT; MALE; MIDDLE AGED; NEPAL; NEWBORN; PILOT STUDY; PRESCHOOL CHILD; STATISTICS; TIME; VOMITING;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEPAL; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VOMITING; YOUNG ADULT;

EID: 58149311509     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bates DW and Leape L (2000). Adverse drug reaction. In: Morreli's Clinical Pharmacology, Carvuthers SG, Hoffman BB, Melmon KL and Nierenberg DW (editors), McGraw-Hill, Boston, pp. 1223-1257.
2. Blum NL. Rational pharmaceutical management project United States Pharmacopoeia: Drug information Development. A case study, Nepal
3. Hartwig SC, Siegel J and Schneider PJ (1992). Preventability and severity assessment in reporting adverse drug reactions. Am. J. Hosp. Pharm., 49: 2229-2232.
4. Holland EG and Degruy FV (1997). Drug-Induced Disorders. Am. Fam. Physician. 56: 7.
5. Kaye K (2004). Trouble with tramadol. Aust. Prescr., 27: 26-27.
6. Lau PM, Stewart K and Dooley MJ (2003). Comment: hospital admissions resulting from preventable adverse drug reactions. Ann. Pharmacother., 37(2): 303-304.
7. Lazarou J, Pomeranz BH and Corey PN (1998). Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J. Am. Med. Assoc., 279(15): 1200-1205.
8. Lee A and Thomas SHL (2003). Adverse drug reactions In: Walker R and Edward C. Clinical pharmacy and Therapeutics. 3rd edition, Churchill Livingstone, pp. 33-46.
9. McEvoy GK, Miller J, Litvak K, Dewey DR, Bollinger LA, Shick J, Millikan EDDouglas PM (editors) (2003). AHFS Drug Information United States of America: American Society of Health-System Pharmacists, pp. (1-3732).
10. Mishra P, Subish P, Gupta S, Shankar PR, Bista D, Chhetri AK and Bhandari RB (2006). Pattern and economic impact of cutaneous adverse drug reactions; initial experiences from the regional pharmacovigilance center, Western Nepal. International Journal of Risk and Safety in Medicine, 8(3): 163-171.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. (1981). A method for estimating the probability of adverse drug reactions. Clin. Pharmacol .Ther., 30: 239-245.
12. Puavilai S and Timpatanapong P (1989). Prospective study of cutaneous drug reactions, J. Med. Assoc. Thai., 72: 167-71.
13. Pudukadan D and Thappa DM (2004). Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India, Indian. J. Dermatol. Venereol. Leprol., 70: 20-24.
14. Shrestha R, Shakya S, Bista D, Shrestha RK, Khan GM, Joshi S, Rao BS. (2006). Case studies of hospitalized patients due to drug related complications. Kathmandu university journal of science, engineering and technology, Vol.II, No.1, February (available on: http://www.ku.edu.np/kuset/second-issue/o2/Rajeev. pdf).
15. Sushma M, Noel MV, Ritika MC, James J and Guido S (2005). Cutaneous adverse drug reactions: a 9-year study from a South Indian hospital. Pharmacoepidemiol. Drug Saf., 14: 567-570.